Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors

Pharmaceutics(2024)10.3390/pharmaceutics16121528Source: DataRank Database

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors is a research paper published in Pharmaceutics (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Nicholas S. Selvo,David Van Mater ORCID,Clinton F. Stewart ORCID,John C. Panetta ORCID

Live enrichment

PubMed:39771507 PMC:PMC11676693 OpenAlex:https://openalex.org/W4404829175

Cancer Center Support (CORE)

Grant: CA021765

Cancer Center Support (CORE)

Grant: 2UM1CA081457

NIH HHS

Grant: 1P30CA021765-25A1

NIH HHS

Grant: 1UM1CA081457-25A1

NCI NIH HHS

Grant: P30 CA021765

NCI NIH HHS

Grant: UM1 CA081457

National Institutes of Health

Grant: 2UM1CA081457-16

Pediatric Brain Tumor Consortium (PBTC)

American Lebanese Syrian Associated Charities (ALSACs)

National Institutes of Health

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by

journalhttps://doi.org/10.3390/pharmaceutics16121528

publisherhttps://doi.org/10.3390/pharmaceutics16121528

publisherhttps://www.mdpi.com/1999-4923/16/12/1528/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39771507

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11676693

Fields of Study

Advanced Breast Cancer TherapiesNeuroendocrine Tumor Research AdvancesLung Cancer Research Studies0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

PalbociclibPharmacodynamicsPharmacokineticsMedicinePopulationNeutropeniaFebrile neutropeniaPharmacologyInternal medicineChemotherapyCancerBreast cancerMetastatic breast cancerBrain tumorsPediatricsNonlinear Mixed-effects ModelingSpecial PopulationsPk/pd ModelsCdk4/6ArticleRS1-441Pharmacy and materia medica

Sustainable Development Goals

SDG 0: Good health and well-being

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors

FAIR Checklist

Authors (4)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)